Big Brother Wants Your Genes

Uncle Sam wants you — or at least your DNA. That's the takeaway from the new "All of Us" research program at the National Institutes of Health.

The initiative aims to collect electronic health records and DNA samples from at least one million Americans. Any person 18 or older is eligible to participate. Researchers hope the donated data will help them better understand diseases and develop more personalized treatments.

This new effort is well-intentioned. But it could put donors' privacy at risk.

Whether donating samples to the federal government or sending in a cheek swab to a private testing outfit like 23andMe, there's no risk-free way to share personal genetic data. Before parting with their DNA, citizens should understand their privacy rights and know how that data will be used.

The NIH's recent announcement comes amid a boom in consumer genetic testing. Along with 23andMe, companies like AncestryDNA and Orig3n let customers discover their ancestral origins and learn which diseases run in their family. One firm, Vinome, even recommends wines based on DNA test results.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no...  Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab...  Read more

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

DRUGWONKS BLOG